Egypt’s PM inaugurates BioGeneric Pharma factory for mRNA vaccines, biologics

Egyptian Prime Minister Moustafa Madbouly has inaugurated on Saturday a factory owned by pharmaceutical company BioGeneric Pharma, to produce mRNA vaccines and biologics.

The factory lies over an area of 20,000 square metres and consists for three main units for the production of Active Pharmaceutical Ingredient (API) and automatic packaging, it is located at northern Egypt’s 10th of Ramadan City.

BioGeneric Pharma aims to achieve self-sufficiency for serums, vaccines, and biologics to reduce reliance on imported products and expand exports to African and international markets, the Cabinet stated.

The company will receive a delegation from the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC) in February, to discuss cooperation opportunities regarding the export of vaccines to the African markets.

This would help increase Egyptian exports in this field after obtaining the necessary global export licenses in order to achieve the sustainable development goals (SDGs) and Egypt’s Vision 2030, the statement said.